Description
Table of Contents 1. Behavioural variant FTD: recent advances in the diagnosis and understanding of the disorder John Hodges, Olivier Piguet, Rebekah Ahmen 2. The neuropsychiatry of frontotemporal dementia Bruce Miller 3. Nosology and Neuropathology of Language in Primary Progressive Aphasia Marsel Mesulam, S. Weintraub, E. Rogalski, E. Bigio 4. Measuring Behavior and Cognition in FTLD Kate Rankin et al 5. Clinical update on C9orf72: FTD, ALS and beyond Isabelle Le Ber and Brad Boeve 6. Clinical aspects of familial FTLD associated with MAPT and GRN mutations Brad Boeve and Howie Rosen 7. Neuroimaging in Frontotemporal Lobar Degeneration Sheena Dev, Bradford C. Dickerson, Alexandra Touroutoglou 8. The FTD Prevention Initiative – linking together genetic FTD cohort studies Jonathan Rohrer and Adam Boxer 9. Fluid Biomarkers of Frontotemporal Lobar Degeneration John van Swieten and Emma van der Ende 10. Cross-cultural perspectives on frontotemporal degeneration Chiadi U. Onyike et al 11. Clinical characteristics and Neuropathology of PSP, CBD and Related 4R-Tauopathies Dennis Dickson, Irene Litvan, D.Coughlin, Keith A. Josephs 12. Tau protein and frontotemporal dementias Michel Goedert, Maria G Spillantini 13. FTLD-TDP pathological subtypes: clinical and mechanistic significance Manuela Neumann, Edward Lee, Ian Mackenzie 14. Lysosomal dysfunction as a pathogenic mechanism in FTD: Evidence from PGRN and TMEM106B genetics and biology Xiaolai Zhou, Thomas Kukar, Rosa Rademakers 15. Future trends in understanding the pathological role of TDP-43 and FUS proteins Emanuele Buratti 16. Description of a new data resource for FTD including multiomic data on human post mortem brain (MAPT, GRN, C9orf72), matching mouse models and iPS models Peter Heutink and Kevin Menden 17. Mendelian and sporadic FTD: avenues from genetics to disease pathways through in-silico prediction and modeling Raffaele Ferrari 18. FTLD treatment: Current Practice and Future Possibilities Adam Boxer and Peter Ljubenkov
